reviewCurrent Opinion in ImmunologyJan 9, 2012Closed access

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

SLSuzanne L. Topalian CGCharles G. Drake DMDrew M. Pardoll

Johns Hopkins University · Sidney Kimmel Comprehensive Cancer Center

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,341

total citations

FWCI: 53.35
Percentile: 100%
References: 43

Citations per year

Authors

3

SL
Suzanne L. TopalianCorresponding
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
CG
Charles G. Drake
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
DM
Drew M. Pardoll
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Topics & keywords

Topics

Keywords

Tumor microenvironment
Immune checkpoint
Immune system
Cancer immunotherapy
Immunotherapy
Blockade
Cancer research
Epigenetics

No related works found for this paper.